Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Diethyldioxystilbene Diphosphate
2. Diethylstilbestrol Diphosphate
3. Difostilben
4. Fosfesterol
5. Fosfestrol, (e)-isomer
6. Fosfestrol, 99tc-labeled Cpd
7. Fosfestrol, Disodium Salt, (e)-isomer
8. Fosfestrol, Sodium Salt, (e)-isomer
9. Fosfestrol, Tetrasodium Salt, (e)-isomer
10. Fostestrolum
11. Fostrolin
12. Honvan
13. Kyorin
14. St-52
15. Stilbestrol Diphosphate
16. Stilphostrol
1. Diethylstilbestrol Diphosphate
2. 522-40-7
3. Phosphestrol
4. Honvan
5. Stilbestrol Diphosphate
6. Phosphoestrolum
7. (e)-hex-3-ene-3,4-diylbis(4,1-phenylene) Bis(dihydrogen Phosphate)
8. Fosfestrol [inn]
9. A0e0nma80f
10. [4-[(e)-4-(4-phosphonooxyphenyl)hex-3-en-3-yl]phenyl] Dihydrogen Phosphate
11. Chebi:4532
12. Diethylstilbestrol Diphosphate [usp]
13. Ncgc00181335-01
14. Desdp
15. St52-asta
16. Stilphostrol (tn)
17. Diethylstilbestryl Diphosphate
18. Diethylstilbesterol Diphosphate
19. Fosfestrolum
20. Diethylstilbestrol Diphosphate (usp)
21. Fosfestrolum [inn-latin]
22. Ccris 2778
23. Einecs 208-328-8
24. Unii-a0e0nma80f
25. Phenol, 4,4'-((1e)-1,2-diethyl-1,2-ethenediyl)bis-, Bis(dihydrogen Phosphate)
26. Phenol, 4,4'-[(1e)-1,2-diethyl-1,2-ethenediyl]bis-, Bis(dihydrogen Phosphate)
27. 13425-53-1
28. Fosfestrol [mi]
29. Fosfestrol (jan/inn)
30. Fosfestrol [jan]
31. Alpha,alpha'-diethyl-(e)-4,4'-stilbenediol Bis(dihydrogen Phosphate)
32. Fosfestrol [mart.]
33. Schembl9370
34. Dsstox_cid_26906
35. Dsstox_rid_82005
36. Fosfestrol [who-dd]
37. Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, Bis(dihydrogen Phosphate), (e)-
38. Dsstox_gsid_46906
39. Diethylstilbestrol Bisphosphate
40. Chembl1200598
41. Dtxsid3046906
42. (e)-4,4'-(hex-3-ene-3,4-diyl)bis(4,1-phenylene) Bis(dihydrogen Phosphate)
43. 3-hexene-3,4-diylbis(4,1-phenylene) Bis[dihydrogen (phosphate)]
44. Zinc1531012
45. Tox21_112794
46. 4,4'-stilbenediol, Alpha,alpha'-diethyl-, Bis(dihydrogen Phosphate), (e)-
47. Akos005267157
48. Cas-522-40-7
49. 3,4-bis[p-(phosphonooxy)phenyl]-3-hexene
50. Bb 0266147
51. Diethylstilbestrol Diphosphate [vandf]
52. C08145
53. D00946
54. Sr-01000945066
55. Diethylstilbestrol Diphosphate [orange Book]
56. Q1003185
57. Sr-01000945066-1
58. .alpha.,.alpha.'-diethyl-(e)-4,4'-stilbenediol Bis(dihydrogen Phosphate)
59. [4-[(e)-1-ethyl-2-(4-phosphonooxyphenyl)but-1-enyl]phenyl] Dihydrogen Phosphate
60. 4-{1-ethyl-2-[4-(phosphonooxy)phenyl]-1-butenyl}phenyl Dihydrogen Phosphate
61. Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, Bis(dihydrogen Phosphate), (e)
| Molecular Weight | 428.3 g/mol |
|---|---|
| Molecular Formula | C18H22O8P2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | 428.07899165 g/mol |
| Monoisotopic Mass | 428.07899165 g/mol |
| Topological Polar Surface Area | 134 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 568 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
L - Antineoplastic and immunomodulating agents
L02 - Endocrine therapy
L02A - Hormones and related agents
L02AA - Estrogens
L02AA04 - Fosfestrol
Market Place
ABOUT THIS PAGE
61
PharmaCompass offers a list of Fosfestrol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosfestrol manufacturer or Fosfestrol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosfestrol manufacturer or Fosfestrol supplier.
PharmaCompass also assists you with knowing the Fosfestrol API Price utilized in the formulation of products. Fosfestrol API Price is not always fixed or binding as the Fosfestrol Price is obtained through a variety of data sources. The Fosfestrol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fosfestrol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosfestrol, including repackagers and relabelers. The FDA regulates Fosfestrol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosfestrol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fosfestrol supplier is an individual or a company that provides Fosfestrol active pharmaceutical ingredient (API) or Fosfestrol finished formulations upon request. The Fosfestrol suppliers may include Fosfestrol API manufacturers, exporters, distributors and traders.
Fosfestrol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosfestrol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosfestrol GMP manufacturer or Fosfestrol GMP API supplier for your needs.
A Fosfestrol CoA (Certificate of Analysis) is a formal document that attests to Fosfestrol's compliance with Fosfestrol specifications and serves as a tool for batch-level quality control.
Fosfestrol CoA mostly includes findings from lab analyses of a specific batch. For each Fosfestrol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosfestrol may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosfestrol EP), Fosfestrol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosfestrol USP).
